共 50 条
- [21] Safety and immunogenicity of RTS,S+TRAP malaria vaccine, formulated in the AS02A adjuvant system, in infant rhesus monkeysAMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 70 (05): : 499 - 509Walsh, DSPichyangkul, SGettayacamin, MTongtawe, PSiegrist, CAHansukjariya, PKester, KEHolland, CAVoss, GCohen, JStewart, AVMiller, RSBallou, WRHeppner, DG
- [22] Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan AfricaVACCINE, 2020, 38 (04) : 897 - 906Otieno, LucasMendoza, Yolanda GuerraAdjei, SamuelAgbenyega, TsiriAgnandji, Selidji TodagbeAide, PedroAkoo, PaulineAnsong, DanielAsante, Kwaku PokuBerkley, James A.Gesase, SamwelHamel, Mary J.Hoffman, IrvingKaali, SeyramKamthunzi, PortiaKariuki, SimonKremsner, PeterLanaspa, MiguelLell, BertrandLievens, MarcLusingu, JohnMalabeja, AnangisyeMasoud, Nahya SalimMtoro, Ali TakadirNjuguna, PatriciaOfori-Anyinam, OpokuaOtieno, Godfrey AllanOtieno, WalterOwusu-Agyei, SethSchuerman, LodeSorgho, HermannTanner, MarcelTinto, HalidouValea, InnocentVandoolaeghe, PascaleSacarlal, JahitOneko, Martina
- [23] A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adultsVACCINE, 2007, 25 (29) : 5359 - 5366Kester, Kent E.McKinney, Denise A.Tornieporth, NadiaOckenhouse, Christian F.Heppner, D. Gray, Jr.Hall, TedWellde, Bruce T.White, KateSun, PeifangSchwenk, RobertKrzych, UrszulaDelchambre, MartineVoss, GeraldDubois, Marie-ClaudeGasser, Robert A., Jr.Dowler, Megan G.O'Brien, MeganWittes, JanetWirtz, RobertCohen, JoeBallou, W. Ripley
- [24] PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDRENAMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 9 - 9Bejon, P.Lusingu, J.Olotu, AllyLeach, A.Lievens, M.Vekemans, J.Msham, S.Lang, T.Gould, J.Dubois, M. C.Demoitie, M. A.Vansadia, P.Carter, T.Njuguna, P.Kawuondo, K.Gesase, S.Drakeley, C.Savarese, B.Villafana, T.Ballou, W. R.Cohen, J.Riley, E.Lemnge, M.Marsh, K.von Seidlein, L.
- [25] Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trialNATURE MEDICINE, 2021, 27 (09) : 1636 - +Oneko, MartinaSteinhardt, Laura C.Yego, ReubenWiegand, Ryan E.Swanson, Phillip A.Natasha, K. C.Akach, DorcasSang, TonyGutman, Julie R.Nzuu, Elizabeth L.Dungani, AllanSim, B. Kim LeeOloo, Paul NdayaOtieno, KephasBii, Dennis K.Billingsley, Peter F.James, Eric R.Kariuki, SimonSamuels, Aaron M.Jongo, SaidChebore, WinnieAbdulla, SalimDaubenberger, ClaudiaMpina, MaxmillianStyers, DavidPotter, Gail E.Abarbanell, GinnieRichie, Thomas L.Hoffman, Stephen L.Seder, Robert A.
- [26] Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trialNature Medicine, 2021, 27 : 1636 - 1645Martina OnekoLaura C. SteinhardtReuben YegoRyan E. WiegandPhillip A. SwansonNatasha KCDorcas AkachTony SangJulie R. GutmanElizabeth L. NzuuAllan DunganiB. Kim Lee SimPaul Ndaya OlooKephas OtienoDennis K. BiiPeter F. BillingsleyEric R. JamesSimon KariukiAaron M. SamuelsSaid JongoWinnie CheboreSalim AbdullaClaudia DaubenbergerMaxmillian MpinaDavid StyersGail E. PotterGinnie AbarbanellThomas L. RichieStephen L. HoffmanRobert A. Seder
- [27] Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria Is Not EndemicCLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (10) : 1552 - 1559El Sahly, H. M.Patel, S. M.Atmar, R. L.Lanford, T. A.Dube, T.Thompson, D.Sim, B. K. L.Long, C.Keitel, W. A.
- [28] Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trialLANCET INFECTIOUS DISEASES, 2015, 15 (12): : 1450 - 1458White, Michael T.Verity, RobertGriffin, Jamie T.Asante, Kwaku PokuOwusu-Agyei, SethGreenwood, BrianDrakeley, ChrisGesase, SamwelLusingu, JohnAnsong, DanielAdjei, SamuelAgbenyega, TsiriOgutu, BernhardsOtieno, LucasOtieno, WalterAgnandji, Selidji T.Lell, BertrandKremsner, PeterHoffman, IrvingMartinson, FrancisKamthunzu, PortiaTinto, HalidouValea, InnocentSorgho, HermannOneko, MartinaOtieno, KephasHamel, Mary J.Salim, NahyaMtoro, AliAbdulla, SalimAide, PedroSacarlal, JahitAponte, John J.Njuguna, PatriciaMarsh, KevinBejon, PhilipRiley, Eleanor M.Ghani, Azra C.
- [29] Long-term immunogenicity and immune memory response to the hepatitis B antigen in the RTS,S/AS01E malaria vaccine in African children: a randomized trialHUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1464 - 1470Valea, InnocentAdjei, SamuelUsuf, EffuaTraore, OusmaneAnsong, DanielTinto, HalidouBoateng, Harry OwusuSome, Athanase MwinessobaonfouBuabeng, PatrickVekemans, JohanKotey, AmosVandoolaeghe, PascaleCullinane, MarkTraskine, MagaliOuedraogo, FlorenceSambian, DavidLievens, MarcTahita, Marc ChristianJongert, ErikLompo, PalpouguiniIdriss, AliBorys, DorotaOuedraogo, SayoubaPrempeh, FrankSchuerman, LodeSorgho, HermannAgbenyega, Tsiri
- [30] Safety and immunogenicity of RTS, S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trialLANCET INFECTIOUS DISEASES, 2016, 16 (10): : 1134 - 1144Otieno, LucasOneko, MartinaOtieno, WalterAbuodha, JosephOwino, EmmanuelOdero, ChrisMendoza, Yolanda GuerraAndagalu, BenAwino, NorbertIvinson, KarenHeerwegh, DirkOtsyula, NekoyeOziemkowska, MariaUsuf, Effua AbigailOtieno, AllanOtieno, KephasLeboulleux, DidierLeach, AmandaOyieko, JanetSlutsker, LaurenceLievens, MarcCowden, JessicaLapierre, DidierKariuki, SimonOgutu, BernhardsVekemans, JohanHamel, Mary J.